DaTscan™, our DaT SPECT Imaging Agent, is celebrating 10 years of FDA approval!
As a committed partner in the Neuroimaging community, we would like to thank you for being part of this incredible journey with us! Thanks to you, DaTscan has been used to perform more than 250,000 scans1 over the past 10 years.
This milestone is a testament to GE Healthcare's heritage in the Neurology community and the partnerships we have forged with the Imaging Centers and referring physicians, such as yourselves.
Over the past decade, we have established a robust and reliable logistics network, achieving 99% on-time delivery in 2019.¹ In 2020, with the pandemic, we ALL faced many challenges that tested our resiliency and determination but together we worked tirelessly to resolve and overcome those challenges, so we can continue to contribute and deliver the highest standard of patient care.
Looking to the future, we prepared for the US market's growing demand and increased manufacturing capacity for DaTscan in our Arlington Heights site. We also invested $20M towards a new automated manufacturing plant to further expand capacity.
We remain committed to providing the highest quality manufacturing and distribution services to our customers. Thank you for your continuous support of GE Healthcare and the advancement of Neurology.
Please see Full Prescribing Information for DaTscan here.